In the North American medical devices industry, there were 17 private equity deals announced in Q2 2023, worth a total value of $2.3bn, according to GlobalData’s Deals Database. The $2.1bn institutional buy-out (ibo) oneoncology by AmerisourceBergen and TPG Capital was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, private equity deal activity in North America increased by 959% in Q2 2023 compared with the previous quarter’s total of $217.1m and rose by 67% as compared to Q2 2022. Related deal volume increased by 13% in Q2 2023 versus the previous quarter and was 6% higher than in Q2 2022.
The top-ranked financial advisors supporting these private equity deals in North America in Q2 2023 were Piper Sandler Companies; Guggenheim Partners; Harris Williams with 3, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in North America Q2 2023 were Morgan, Lewis & Bockius; Ropes & Gray; Wilson Sonsini Goodrich & Rosati Professional with 2, 2, 2 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
Smarter leaders trust GlobalData
Premium Insights Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in 2022 -Thematic Intelligence
Premium Insights
The gold standard of business intelligence.
